Plethico Pharmaceuticals Ltd Half Yearly Results

Gross Sales

221.78

536.15

803.16

943.61

887.47

Excise Duty

0

0

0

0

0

Net Sales

221.78

536.15

803.16

943.61

887.47

Other Operating Income

2.52

4.67

7.79

65.09

-17.33

Other Income

-0.03

0.02

0.17

1.33

8.29

Total Income

224.27

540.86

811.13

1,010.04

878.43

Total Expenditure

532.79

438.54

657.11

892.15

850.89

PBIDT

-308.53

102.31

154.02

117.88

27.54

Interest

33.3

88.25

51.59

50.7

33.1

PBDT

-341.83

14.06

102.42

67.18

-5.56

Depreciation

27.25

30.64

34.65

13.78

8.57

Minority Interest Before NP

0

0

0

0

0

Tax

-99.34

-8.6

2.73

-4.23

-6.57

Deferred Tax

0

0

0

0

0

Reported Profit After Tax

-269.74

-7.98

65.04

57.63

-7.56

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

-269.74

-7.98

65.04

57.63

-7.56

Extra-ordinary Items

-319.56

0

0

-32.95

-10.49

Adjusted Profit After Extra-ordinary item

49.82

-7.98

65.04

90.59

2.93

EPS (Unit Curr.)

0

-2.33

19.09

16.92

0

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

34.07

34.06

34.07

34.06

34.07

Public Shareholding (Number)

96,45,975

96,50,237

78,55,737

75,95,622

58,92,622

Public Shareholding (%)

28.31

28.32

23.06

22.29

17.3

Pledged/Encumbered - No. of Shares

2,09,37,385

2,09,37,384

2,27,31,885

2,29,92,000

2,75,64,950

Pledged/Encumbered - % in Total Promoters Holding

85.74

85.75

86.73

86.86

97.84

Pledged/Encumbered - % in Total Equity

61.46

61.45

66.73

67.48

80.91

Non Encumbered - No. of Shares

34,83,307

34,79,045

34,79,045

34,79,045

6,09,095

Non Encumbered - % in Total Promoters Holding

14.26

14.25

13.27

13.14

2.16

Non Encumbered - % in Total Equity

10.22

10.21

10.21

10.21

1.79

PBIDTM(%)

-139.11

19.08

19.17

12.49

3.1

PBDTM(%)

-

-

-

-

-

PATM(%)

-121.62

-1.48

8.09

6.1

-0.85